Skip to main content
International Journal of Clinical and Experimental Medicine logoLink to International Journal of Clinical and Experimental Medicine
. 2015 May 15;8(5):7737–7745.

MTHFD1 gene polymorphisms as risk factors involved in orofacial cleft: an independent case-control study and a meta-analysis

Jun Wu 1, Yafei Chen 1, Jun Pei 1, Jian Pan 1
PMCID: PMC4509269  PMID: 26221324

Abstract

Background: Orofacial clefts (OFCs) were among the most familiar birth defects in the world, which had been reported to be influenced by the folic acid ingestion in pregnancy previously. Methylenetetrahydrofolate dehydrogenase1 (MTHFD1) gene was associated with the susceptibility of OFCs through a complex metabolism correlate with folic acid. The aim of our study was to evaluate the correlation of five single-nucleotide polymorphisms (SNPs) within MTHFD1 related to the OFCs risk in a Chinese population. Methods: By the use of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), we genotyped 5 filtered SNPs (identified by Haploview 4.2 software with HapMap databases) on MTHFD1 gene: 118913T>C, 31136A>G, 58893A>G, 1958G>A and 61869T>C of 216 subjects (108 OFCs cases and 108 healthy controls) from a Chinese population. The association between these SNPs and OFCs risk was investigated by student t-test, one-way analysis of variance (ANOVA) and chi-square test with GraphPad Prism 5.0 software. Furthermore, we also performed a meta-analysis of relevant studies to investigate the association between MTHFD1 1958G>A and the susceptibility of OFCs. Results: Through the genotyping, the AA genotype was found significantly correlated with the susceptibility of OFCs compared with other SNPs on MTHFD1, yielding an OR of 2.71 (95% CI = 1.12-6.58, P = 0.025) under the homozygous model and an OR of 2.37 (95% CI = 1.06-5.30, P = 0.033) under the recessive model. While other selected SNPs 118913T>C and 31136A>G were also associated with an increased OFC risk, the results were not statistically significant (all P > 0.05). However, the overall result of meta-analysis did not support the conclusion that the 1958G>A variant could be a genetic susceptible factor for OFCs (A allele vs. G allele: OR = 1.02, 95% CI = 0.85-1.23, AA vs. GG: OR = 1.06, 95% CI = 0.69-1.63, GA vs. GG: OR = 1.02, 95% CI = 0.81-1.27, AA vs. GG+GA: OR = 0.94, 95% CI = 0.61-1.46, AA+GA vs. GG: OR = 0.94, 95% CI = 0.74-1.19). Conclusions: The MTHFD1 1958G>A variant was significantly associated with the increased OFCs risk in Chinese population. However, this association was not supported by meta-analysis of all relevant studies. Further investigations about functional impact of this polymorphism were needed.

Keywords: Orofacial cleft, methylenetetrahydrofolate dehydrogenase (MTHFD1), polymorphism, folate metabolism

Introduction

Orofacial clefts (OFCs) are among the most familiar birth defects all over the world, which may leave a long distressing life for the patients [1]. OFCs could be classified in cleft lip with or without cleft palate (CLP), cleft palate only (CPO) and cleft lip only (CLO). Previous epidemiologic studies for OFCs suggested that the overall birth prevalence was around 0.1%-0.2%, but this value varies among different races and districts [2-5]. OFCs are chiefly suffered in Asian population, followed by Caucasian population while the risk in African and American population is the lowest [6]. The risk of OFCs could be affected by both complex environmental and genetic factors [7]. Based on previous epidemiologic researches on this cohort, many environmental factors like folate supplementation and smoking were stated. Early in 1971, the study in twins by Hay et al. supported that the special environment in uterus is a robust risk factor within the craniofacial disorder [8]. Numerous researchers had conclusively supported that the ingestion of folic acid supplementation during pregnancy was probably an access to the precaution of several congenital anomalies [5], though these associations still remain controversial, with some others did not found the correlation [9]. On the other hand, it was hypothesized that some genes take part in the folate metabolism would be also correlated with the birth defects including OFCs. The observation of OFCs recurrence under inheritance act as substantial evidence, also suggesting the genetic factors might lead to OFCs. Further, piles of single-nucleotide polymorphisms (SNPs) were verified to result in birth defects occurrence or the manifestation of OFCs, and some gene-gene and gene-environment interactions were also observed to play a role in the aetiology.

Methylenetetrahydrofolate dehydrogenase1 (MTHFD1) gene is verified to be one of the genes involved in folate metabolism which locates on chromosome 14q23.3. MTHFD1 is a nicotinamide adenine dinucleotide phosphate (NADP)-dependent trifunctionala cytoplasmic enzyme (often referred to as “C1-THF synthase”) in three sequential reactions, and it plays an important role in the one-carbon (1C) derivatives of tetrahydrofolate, which could derive 10-formylotetrahydrofolate (10-FTH), 5,10-methenyltetrahydrofolate cyclohydrolase (5,10-methenylTHF cyclohydrolase), and 5,10-methylenetetrahydrofolate dehydrogenase (5,10-MTHFD) [10]. It had been reported that several SNPs on MTHFD1 gene could influence the homocysteine and folic acid levels in serum [11,12], and was further associated with several cancers, migraine, congenital anomalies like NTDs and congenital heart disease [13-15].

Though the MTHFD1 gene had been world widely researched in the fields of OFCs, the findings were contradictory in the previous studies and the relative studies in Asian population still need more robust testimonies. Hence, in our study, we filtered 5 representative SNPs on MTHFD1: 18913T>C (rs8006686), 31136A>G (rs2357694), 58893A>G (rs8003567), 1958G>A (rs2236225) and 61869T>C (rs1256143) from the database of International HapMap Project (HapMap Data Rel 24/phaseII Nov08, on NCBI B36 assembly, dbSNP b126) to clarify the association of the SNPs on MTHFD1 with the OFCs risk in a Chinese population. Furthermore, considering the limitation of individual study with small sample size, we also performed a meta-analysis of the association between MTHFD1 SNP 1958G>A and OFCs susceptibility based on all the available public data, in order to reinforce the overall result.

Material & methods

Study population

The study we performed was consisted of 216 subjects in the protocol from April 2012 to May 2014, approved by the ethics review board of East Hospital (Shanghai, China). All the subjects recruited were filtered based on the characteristic of the neonate, the parents and their family history, regarding the level of OFCs and some possible influential factors which may lead to OFCs of the maternal. The subjects were comprised of 108 cases who were neonates OFCs sufferers from oral and maxillofacial surgery and other 108 normal controls randomly selected from the unrelated healthy neonates without family history of OFCs from inpatients of the gynecology and obstetrics department. We further classified the subjects in case group by the certainly diagnosis of their cleft sort in three subgroups: CLP, CPO and CLO (the characteristic details are showed in Table 2). For the entire specimens in our study, 5 ml peripheral blood samples were collected with EDTA vacutainer for next assays. Each specimen’s data were available for following up. An informed consent granted by the institutional ethics committee of East Hospital must be signed by each volunteer (as for the neonates, the informed consent must be signed instead by their parents or guardians).

Table 2.

Comparison of patients and controls by selective characteristics

Clinical characteristics Cases group Controls group P value
Total 108 108
Age at conception (mean ± SD) 23.8±5.32 22.7±6.33 0.894
Maternal Smoking
    ever 67 (62.0%) 53 (49.1%) 0.055
    never 41 (38.0%) 55 (50.9%)
Alcohol drinking during pregnancy
    ever 77 (71.3%) 42 (38.9%) < 0.001
    never 31 (28.7%) 66 (61.1%)
Folate supplementation
    no 76 (70.4%) 51 (47.2%) < 0.001
    yes 32 (29.6%) 57 (52.8%)
Offspring sex
    male 60 (55.6%) 58 (53.7%) 0.785
    female 48 (44.4%) 50 (46.3%)
Type of cleft
    CLO 29 (26.9%) -
    CLP 53 (49.1%) -
    CPO 26 (24.0%)

SNP selection

In this study, we select 16 SNPs on MTHFD1 from the genome browser. The SNPs were from unrelated Chinese individuals in the public genotype database according to Chinese HapMap Consortium. The selection of the tag-SNPs was dependent on the pairwise option of the Haploview 4.2 software, the linkage disequilibrium (LD) pattern using HapMap genotype data and r2 of 0.8 was selected as a threshold for the analyses [16,17]. As a result, we filtered 5SNPs as representatives on MTHFD1: 118913T>C, 31136A>G, 58893A>G, 1958G>A and 61869T>C. Through previous studies these SNPs had a high incidence and were supposed to result in amino acid change which would further vary the function of related enzymes [18]. The linkage disequilibrium plot of all the 16 SNPs on MTHFD1 gene was presented by the Haploview 4.2 software and showed in Figure 1. The approximate locations of the selected SNPs on MTHFD1 gene were as following: 118913T>C was on intron 2, the 31136A>G was on intron 4, the 58893A>G was on intron 17, the 1958G>A was on exon 19 and the 61869T>C was on intron 19 regions, as demonstrated in Figure 2.

Figure 1.

Figure 1

Linkage disequilibrium of the sixteen tag-SNPs.

Figure 2.

Figure 2

Genetic location of the selected five tag-SNPs.

Genotyping method

We isolated the whole genomic DNA from peripheral blood samples with the QIAamp DNA Blood Mini Kit (Qiagen Biosciences, Germany) as performed in Shaffer et al.’s assay [19]. For all polymorphisms, genotyping quality was verified by repeat analysis genotyping of at least 10% of the samples by the initial genotyping method or direct sequencing with > 99% agreement for the five polymorphisms [20]. The SNPs we assayed were selected through HapMap previously and had been studied for their mechanism. The genotyping of the 5 polymorphic sites on MTHFD: 118913T>C, 31136A>G, 58893A>G, 1958G>A and 61869T>C were done by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. We used the Primer Premier 5 software designing the primers for the 5 selected SNPs as showed in Table 1. The cycle sequencing was performed according to the manufacturer’s instructions. The primers and conditions of all assays are available upon request. And the gene positions, primers for PCR amplification and Minor Allele Frequency (MAF) were revealed in Table 1.

Table 1.

Primers of MTHFD1 gene polymorphisms for PCR amplification

SNP Gen Pos Alias name Primers for PCR amplification MAF
rs8006686 Intron 2 18913T>C F: 5’-CCTGTATGGCTTAGTAGAA-3’ 0.237
R: 3’-AGGAAGGTCCATTAACAC-5’
rs2357694 Intron 4 31136A>G F: 5’-TTGGTTGTACTAGCCACTT-3’ 0.176
R: 3’-AGACGGGTGAGTTCGGAG-5’
rs8003567 Intron 17 58893A>G F: 5’-TGTGACTGGGACGTTACTG-3’ 0.120
R: 3’-AAGGAAGGCTAAGGTTTA-5’
rs2236225 Exon 19 1958G>A F: 5’-TCCTCCATCATTGCAGAC-3’ 0.342
R: 3’-TCCCAAACATCCAATCACAAA-5’
rs1256143 Intron 19 61869T>C F: 5’-AGATGTACCTCACAAAAT-3’ 0.110
R: 3’-TTACTCATCTATCCCTTC-5’

SNP, single-nucleotide polymorphism; F, forward; and R, reverse.

Statistical analysis

We managed the statistical analysis using the STATA 12.0 software. During the analysis, student t-test and chi-square (χ 2) test were applied to analyze the distribution of the several selected characteristics between OFCs sufferers and healthy controls. Differences of genotype frequencies were also assessed by the χ 2 test. We also implement a chi-square goodness-of-fit test by comparison of observed and expected genotype frequencies to verify the data quality in each subject class, exploring significant departure from Hardy-Weinberg equilibrium (HWE). The genotypes related OFCs risk was assessed by odds ratio (OR) and their corresponding respective confidence intervals 95% (CIs) value, for both combined and respective genotype. A two-sided P value less than 0.05 was considered to be statistically significant for all analyses. Further, we conducted a meta-analysis of all relevant studies on the correlation between 1958G>A on MTHFD1 and OFCs risk.

Results

Study characteristics

We recruited 216 specimens in this study as blood sample donators from East Hospital (Shanghai, China). The specimens were consisted of 108 OFCs sufferers (60 males and 48 females) and 108 healthy controls (58 males and 50 females) as two homogenous groups. Despite the difference among the gender, no significant difference was observed (P = 0.785). Furthermore, the cases group was classified into 29 CLO patients, 53 CLP patients and 26 CPO patients, as showed in Table 2. Besides, due to the possible factors that might have influence on the malformation during pregnancy, the detail characteristics of the neonates’ mothers were also investigated. Through our previous filter, the difference of the age at conception of the mothers in the two groups was not significant (P = 0.894). For the concrete data showed the age at conception in the cases group was 23.8 (SD = 5.32) and in the control group was 22.7 (SD = 6.33). We also considered about the maternal smoking, alcohol drinking and the folate supplementation during pregnancy. The maternal smoking had a weak influence on the susceptibility of OFCs (P = 0.055) without significant difference, while both the alcohol drinking and folate supplementation during pregnancy showed a noteworthy significant difference between the two groups (P < 0.001), respectively. 71.3% mothers in the cases group had ever drunk alcohol during pregnancy. Similarly, 70.4% mothers of the OFCs sufferers took no folate supplementation during the affected pregnancy, more than the mothers in the controls group. The data elucidated the mothers who drank alcohol and did not take appropriate folate supplementation during pregnancy were more likely to have a neonate suffered OFCs (The detailed data on the clinic characteristics are revealed in Table 2).

The associations between MTHFD1 and the risk of orofacial cleft

As indicated in Table 3, all the SNPs we assayed have positive effect with the OFCs susceptibility with their OR values over 1.0. Merely, only the association of MTHFD1 1958G>A on exon19 with the OFCs risk was statistically significant through our analysis, with a P value below 0.05. The MTHFD1 1958G>A genotype was more frequent in OFCs patients than in control groups. The significantly increased risk of OFCs was observed among the specimen with MTHFD1 1958G>A in allele model, homozygote model and recessive model. Under the allele model, compared with the G allele genotype, the A allele genotype had a higher incidence in the OFCs sufferers (A allele vs. G allele: OR = 1.47, 95% CI = 1.00-2.16, P = 0.050). Similarly, a significant positive association was also noticed in recessive model (AA vs. GG+GA: OR = 2.37, 95% CI = 1.06-5.30, P = 0.033). And in homozygote model, a higher level of the significant was observed (AA vs. GG: OR = 2.71, 95% CI = 1.12-6.58, P = 0.025). Besides, no significant difference was noted in neither heterozygote model (P = 0.469) nor Dominant model (P = 0.192).

Table 3.

Associations between five polymorphisms of MTHFD1 gene and the risk of orofacial cleft

Genotype Cases group (n = 258) Controls group (n = 258) OR (95% CI) χ 2 P value
rs2357694 (31136A>G)
    AA 127 143 Ref.
    AG 81 67 1.36 (0.91-2.04) 2.263 0.133
    GG 50 48 1.17 (0.74-1.86) 0.457 0.499
    Recessive (AG+GG vs. AA) 1.28 (0.91-1.81) 1.989 0.159
    Dominant (GG vs. AA+AG) 1.30 (0.89-1.91) 1.857 0.173
    Allele (G allele vs. A allele) 1.17 (0.90-1.52) 1.413 0.235
rs2236225 (1958G>A)
    GG 122 146 Ref.
    GA 102 90 1.36 (0.94-1.97) 2.588 0.108
    AA 34 22 1.85 (1.03-3.33) 4.282 0.039
    Dominant (GA+AA vs. GG) 1.45 (1.03-2.06) 4.472 0.035
    Recessive (AA vs. GG+GA) 1.63(0.92-2.87) 2.884 0.089
    Allele (G allele vs. A allele) 1.40 (1.07-1.83) 6.043 0.014
rs8006686 (18913T>C)
    TT 158 186 Ref.
    TC 53 48 0.85 (0.55-1.31) 0.547 0.459
    CC 47 24 0.98 (0.62-1.56) 0.005 0.942
    Recessive (TC+CC vs. TT) 0.91 (0.64-1.29) 0.290 0.590
    Dominant (CC vs. TT+TC) 1.03 (0.66-1.61) 0.013 0.909
    Allele (C allele vs. T allele) 0.95 (0.73-1.25) 0.118 0.732

OR, odds ratio; CI, confidence interval.

Meta-analysis for the association between MTHFD1 1958G>A and OFCs risk

We performed a meta-analysis to assess the association between MTHFD1 1958G>A and the susceptibility of OFCs. We recruited data from 8 eligible interrelated studies (including the present study) which were all selected through pre-specified search strategy [21-27]. In total, the studies provided the data of 4789 specimens. Among the 1040 specimens from Asian, 515 were OFCs cases and 525 were healthy controls. Besides, the other 3749 Caucasian specimens were consisted of 1637 OFCs cases and 2112 healthy controls. The detail characteristics of 8 included articles were revealed in Table 4. Due to the P-value of chi-squared test is below 0.05 and the I-square is over 50% in all the models we assayed, which means we observed significant heterogeneity among the studies we recruited. We performed the random-effects model in overall analysis. The data in our analysis were divided into two groups (Asian and Caucasian) by the ethnicity. Through all the genetic models analysis, we found no significant association between the MTHFD1 1958G>A variant and the susceptibility of OFCs (A allele vs. G allele: OR = 1.02, 95% CI = 0.85-1.23, AA vs. GG: OR = 1.06, 95% CI = 0.69-1.63, GA vs. GG: OR = 1.02, 95% CI = 0.81-1.27, AA vs. GG+GA: OR = 0.94, 95% CI = 0.61-1.46, AA+GA vs. GG: OR = 0.94, 95% CI = 0.74-1.19). Though statistically significant of the AA genotype variant correlated with OFCs risk was perceived in several articles, the overall result still hold insignificant.

Table 4.

Characteristics of the included studies

First author Year Country Racial descent Sample size Detection method NTD cases Healthy controls


Case Control GG GA AA GG GA AA
Nan XR 2014 China Asian 265 276 PCR-RFLP 113 127 25 100 141 35
Murthy J 2014 India Asian 142 141 PCR-RFLP 21 83 38 42 68 31
de Aquino SN 2014 Brazil Caucasian 181 478 TaqMan 64 91 26 181 211 86
Mostowska A 2010 Poland Caucasian 174 176 PCR-RFLP 49 96 25 35 95 33
Bufalino A 2010 Brazil Caucasian 106 184 PCR-RFLP 35 45 26 64 94 26
Palmieri A 2008 Italy Caucasian 214 212 PCR-RFLP 56 118 40 39 110 63
Mills JL 2008 Ireland Caucasian 962 1062 PCR-RFLP 161 327 152 290 570 202
Present study 2014 China Asian 108 108 PCR-RFLP 31 56 21 40 58 10
Nan XR 2014 China Asian 265 276 PCR-RFLP 113 127 25 100 141 35
Murthy J 2014 India Asian 142 141 PCR-RFLP 21 83 38 42 68 31

Discussion

In this study, we looked into the association between the polymorphism on MTHFD1 gene and the risk of OFCs. We focused on 5 folic acid-related SNPs (118913T>C, 31136A>G, 58893A>G, 1958G>A and 61869T>C) on MTHFD1 gene through our filter in HapMap database. Based on our analysis, only the SNP 1958G>A revealed a convincing association with the incidence of OFCs. Demonstrating that MTHFD1 1958G>A might be considered as a risk factor to OFCs, especially the AA genotype variant perform a high risk to the OFCs. However, the overall result of meta-analysis did not support the conclusion that the 1958G>A variant could be a genetic susceptible factor for OFCs.

It had been reported that the environmental factors such as the maternal smoking, alcohol drinking during pregnancy and vitamin supplementation all have an influence on OFCs susceptibility [21]. In our study, we analyzed the influence of smoking, alcohol drinking and folate supplementation during pregnancy on the susceptibility of OFCs. Our results revealed that these environmental factors all associated with an increased susceptibility of OFCs. But this conclusion remains controversial. For instance, in James et al.’s study on a Dublin population, they failed to find the association between MTHFD1 1958G>A and other environment factors [28]. Besides the environment factors, genetic factors hold a big part of the pathogeny of OFCs. The MTHFD1 gene was a folate related gene which might result in many kind of disease and had been widely researched in several different populations in previous studies. In our study, the minor allele frequency of MTHFD1 1958G>A was 45.37% in cases group and 36.11% in healthy group, close to the level of 34.19% from the public database in NCBI. The frequency of A allele in OFCs sufferers of us was equivalent with the study of Murthy et al. in an Indian population (46.1%) [29], but not as much as in the research of Rai et al., which was also conducted in India (55%) [30]. Demonstrating this SNP variant might be a risk factor for OFCs in Asian population. But this association was failed to be observed in some other countries like Polish [24] and Italy [22]. Nonetheless, since the participation of MTHFD1 in folate metabolism, SNPs on MTHFD1 were associated with many diseases which partly relied on the level of folic acid, such as neural tube defects (NTDs) and congenital heart defects [31].

The MTHFD1 1958G>A variant was verified to be a representative variant on MTHFD1 gene which might change the glutamine (Gln) in 10-formylotetrahydrofolate synthetase region of the MTHFD1 enzyme into arginine (Arg) [32]. In a previous investigation by Christensen et al., it was supported that this substitution could diminish enzyme stability, thermostability and inhibition of de novo purine biosynthesis [33]. Anyway, this shift of the amino acid might result in variation of folate levels and homocysteine status by disturbing the pathway of folate-mediated homocysteine [31,34], and might further reduce the incidence of OFCs neonate. This interaction still requires functional study.

Our results from meta-analysis suggested that MTHFD1 1958G>A could not significantly associated with the OFCs risk in both Asian and Caucasian population, though several researches have reported strong association. Nevertheless, the correlation between this SNP and the OFCs risk was stronger in Asian than in Caucasian, with the OR values in subtotal were all above 1 in Asian compared with the OR values in Caucasian were all below 1. Referable to the complex mechanism the reason was still controversial. It could be supposed that the significance of the risk might be locked in a more specific population, with a combination of non-genetic factors, environmental and social interacted genetic factors and polymorphism distributions.

In our study, the Chinese population we recruited was genetically homogeneous through our early filter. This reduced the probability of stratification and enhances the statistical power of our study’s result. But on the other hand, several limitations should be acknowledged. The sample size of our study was relatively small for more convincing comparisons. The result of this study was not able to further extrapolate due to the bias which was resulted from races and regions related stratification. Regarding to the limitations above, more studies of this polymorphism in different areas and new research on the association between OFCs and other SNPs on MTHFD1 are in need.

In conclusion, our study revealed a significant association between MTHFD1 1958G>A and the OFCs susceptibility in a Chinese population. However, the overall result of meta-analysis did not support the conclusion that the 1958G>A variant could be a genetic susceptible factor for OFCs. Nonetheless, further studies about the exact etiology mechanism of MTHFD1 gene variant 1958G>A in the craniofacial development are recommended.

Acknowledgements

This research was supported by the National Science Funds of China (81200447). We thank all participants who donated samples for this study of oral clefts.

Disclosure of conflict of interest

None.

References

  • 1.Rahimov F, Jugessur A, Murray JC. Genetics of nonsyndromic orofacial clefts. Cleft Palate Craniofac J. 2012;49:73–91. doi: 10.1597/10-178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Butali A, Little J, Chevrier C, Cordier S, Steegers-Theunissen R, Jugessur A, Oladugba B, Mossey PA. Folic acid supplementation use and the MTHFR C677T polymorphism in orofacial clefts etiology: An individual participant data pooled-analysis. Birth Defects Res A Clin Mol Teratol. 2013;97:509–514. doi: 10.1002/bdra.23133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kelly D, O’Dowd T, Reulbach U. Use of folic acid supplements and risk of cleft lip and palate in infants: a population-based cohort study. Br J Gen Pract. 2012;62:e466–472. doi: 10.3399/bjgp12X652328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jia ZL, Shi B, Chen CH, Shi JY, Wu J, Xu X. Maternal malnutrition, environmental exposure during pregnancy and the risk of non-syndromic orofacial clefts. Oral Dis. 2011;17:584–589. doi: 10.1111/j.1601-0825.2011.01810.x. [DOI] [PubMed] [Google Scholar]
  • 5.Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, Vindenes H, Vollset SE, Drevon CA. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ. 2007;334:464. doi: 10.1136/bmj.39079.618287.0B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bhaskar LV, Murthy J, Venkatesh Babu G. Polymorphisms in genes involved in folate metabolism and orofacial clefts. Arch Oral Biol. 2011;56:723–737. doi: 10.1016/j.archoralbio.2011.01.007. [DOI] [PubMed] [Google Scholar]
  • 7.Murthy J, Bhaskar L. Current concepts in genetics of nonsyndromic clefts. Indian J Plast Surg. 2009;42:68–81. doi: 10.4103/0970-0358.53004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hay S, Wehrung DA. Twins with clefts: a descriptive statistical analysis of selected variables. Cleft Palate J. 1971;8:379–386. [PubMed] [Google Scholar]
  • 9.Hayes C, Werler MM, Willett WC, Mitchell AA. Case-control study of periconceptional folic acid supplementation and oral clefts. Am J Epidemiol. 1996;143:1229–1234. doi: 10.1093/oxfordjournals.aje.a008710. [DOI] [PubMed] [Google Scholar]
  • 10.Sutherland HG, Hermile H, Sanche R, Menon S, Lea RA, Haupt LM, Griffiths LR. Association study of MTHFD1 coding polymorphisms R134K and R653Q with migraine susceptibility. Headache. 2014;54:1506–1514. doi: 10.1111/head.12428. [DOI] [PubMed] [Google Scholar]
  • 11.Li Y, Cheng J, Zhu WL, Dao JJ, Yan LY, Li MY, Li SQ. [Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease] . Beijing Da Xue Xue Bao. 2005;37:75–80. [PubMed] [Google Scholar]
  • 12.Shi M, Caprau D, Romitti P, Christensen K, Murray JC. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol. 2003;67:545–549. doi: 10.1002/bdra.10076. [DOI] [PubMed] [Google Scholar]
  • 13.Bressler J, Folsom AR, Couper DJ, Volcik KA, Boerwinkle E. Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study. Am J Epidemiol. 2010;171:14–23. doi: 10.1093/aje/kwp377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Parle-McDermott A, Pangilinan F, O’Brien KK, Mills JL, Magee AM, Troendle J, Sutton M, Scott JM, Kirke PN, Molloy AM, Brody LC. A common variant in MTHFD1L is associated with neural tube defects and mRNA splicing efficiency. Hum Mutat. 2009;30:1650–1656. doi: 10.1002/humu.21109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Konig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453. doi: 10.1056/NEJMoa072366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cao Q, Wang J, Zhang M, Li P, Qian J, Zhang S, Zhang L, Ju X, Wang M, Zhang Z, Li J, Gu M, Zhang W, Qin C, Shao P, Yin C. Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population. PLoS One. 2014;9:e109285. doi: 10.1371/journal.pone.0109285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457. [DOI] [PubMed] [Google Scholar]
  • 18.Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O’Leary VB, Parle-McDermott A, Scott JM, Swanson DA. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002;71:1207–1215. doi: 10.1086/344213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Shaffer A, Hubbard JJ, Townsend K, Kottilil S, Polis MA, Masur H, Kohli A. Short communication: serum-based assay accurately detects single nucleotide polymorphisms of IL28B and SOCS3 in HIV/hepatitis C virus-coinfected subjects. AIDS Res Hum Retroviruses. 2014;30:792–795. doi: 10.1089/aid.2014.0028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Minguzzi S, Molloy AM, Peadar K, Mills J, Scott JM, Troendle J, Pangilinan F, Brody L, Parle-McDermott A. Genotyping of a tri-allelic polymorphism by a novel melting curve assay in MTHFD1L: an association study of nonsyndromic Cleft in Ireland. BMC Med Genet. 2012;13:29. doi: 10.1186/1471-2350-13-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mills JL, Molloy AM, Parle-McDermott A, Troendle JF, Brody LC, Conley MR, Cox C, Pangilinan F, Orr DJ, Earley M, McKiernan E, Lynn EC, Doyle A, Scott JM, Kirke PN. Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. Birth Defects Res A Clin Mol Teratol. 2008;82:636–643. doi: 10.1002/bdra.20491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Palmieri A, Masiero E, Martinelli M, Scapoli L, Pezzetti F, Caramelli E, Guidotti L, Carinci F. The MTHFD1 gene is not involved in cleft lip with or without palate onset among the Italian population. Ann Hum Genet. 2008;72:297–299. doi: 10.1111/j.1469-1809.2007.00428.x. [DOI] [PubMed] [Google Scholar]
  • 23.Bufalino A, Ribeiro Paranaiba LM, Nascimento de Aquino S, Martelli-Junior H, Oliveira Swerts MS, Coletta RD. Maternal polymorphisms in folic acid metabolic genes are associated with nonsyndromic cleft lip and/or palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 2010;88:980–986. doi: 10.1002/bdra.20732. [DOI] [PubMed] [Google Scholar]
  • 24.Mostowska A, Hozyasz KK, Wojcicki P, Dziegelewska M, Jagodzinski PP. Associations of folate and choline metabolism gene polymorphisms with orofacial clefts. J Med Genet. 2010;47:809–815. doi: 10.1136/jmg.2009.070029. [DOI] [PubMed] [Google Scholar]
  • 25.de Aquino SN, Hoshi R, Bagordakis E, Pucciarelli MG, Messetti AC, Moreira H, Bufalino A, Borges A, Rangel AL, Brito LA, Oliveira Swerts MS, Martelli-Junior H, Line SR, Graner E, Reis SR, Passos-Bueno MR, Coletta RD. MTHFR rs2274976 polymorphism is a risk marker for nonsyndromic cleft lip with or without cleft palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol. 2014;100:30–35. doi: 10.1002/bdra.23199. [DOI] [PubMed] [Google Scholar]
  • 26.Murthy J, Gurramkonda VB, Lakkakula BV. Significant association of MTHFD1 1958G<A single nucleotide polymorphism with nonsyndromic cleft lip and palate in Indian population. Med Oral Patol Oral Cir Bucal. 2014;19:e616–21. doi: 10.4317/medoral.19796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nan X, Ren Y, Li RF, Wang JB. Association between folate metabolism-related genes and non-syndromic cleft lip and palate in Shanxi Province. J Pract Stomatol. 2014;30:112–116. [Google Scholar]
  • 28.Wen DZ, Rowland A, Derynck R. Expression and secretion of gro/MGSA by stimulated human endothelial cells. EMBO J. 1989;8:1761–1766. doi: 10.1002/j.1460-2075.1989.tb03569.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Murthy J, Gurramkonda VB, Lakkakula BV. Significant association of MTHFD1 1958G<A single nucleotide polymorphism with nonsyndromic cleft lip and palate in Indian population. Med Oral Patol Oral Cir Bucal. 2014;19:e616–621. doi: 10.4317/medoral.19796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rai PS, Murali TS, Vasudevan TG, Prasada SK, Bhagavath AK, Pai P, Gopinath PM, Satyamoorthy K. Genetic variation in genes involved in folate and drug metabolism in a south Indian population. Indian J Hum Genet. 2011;17(Suppl 1):S48–53. doi: 10.4103/0971-6866.80359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O’Leary VB, Pangilinan F, Conley M, Cleary L, Brody LC, Scott JM. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet. 2006;14:768–772. doi: 10.1038/sj.ejhg.5201603. [DOI] [PubMed] [Google Scholar]
  • 32.Hol FA, van der Put NM, Geurds MP, Heil SG, Trijbels FJ, Hamel BC, Mariman EC, Blom HJ. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet. 1998;53:119–125. doi: 10.1111/j.1399-0004.1998.tb02658.x. [DOI] [PubMed] [Google Scholar]
  • 33.Christensen B, Arbour L, Tran P, Leclerc D, Sabbaghian N, Platt R, Gilfix BM, Rosenblatt DS, Gravel RA, Forbes P, Rozen R. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet. 1999;84:151–157. doi: 10.1002/(sici)1096-8628(19990521)84:2<151::aid-ajmg12>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  • 34.Cheng J, Zhu WL, Dao JJ, Li SQ, Li Y. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect. Biomed Environ Sci. 2005;18:58–64. [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Medicine are provided here courtesy of e-Century Publishing Corporation

RESOURCES